Gelling RW, Du XQ, Dichmann DS, et al
Long-term use of GLP-1 receptor agonists may elevate endogenous GLP-2 release, which further reduces antral motility
Obesity GLP-1 Market Analysis - Size, Share, and Forecast Outlook 2025 to 2035 Industry Size (2025): USD 8169 Mn Forecast (2035): USD 65364 Mn CAGR (2025 to 2035): 23.1% Obesity GLP-1 Market Forecast and Outlook 2025 to 2035 The obesity GLP-1 market is projected to grow from USD 8169 million in 2025 to approximately USD 65,364 million by 2035, recording an absolute increase of USD 57,195 million over the forecast period
How PlexusDx Supports a More Personalized Approach PlexusDx supports evidence-based, prescription-guided GLP-1 therapy through compounded options and precision assessment
Renewable certification keeps you compliant with evolving FDA guidelines and latest treatment protocols
Sen S, Potnuru PP, Hernandez N, Goehl C, Praestholm C, Sridhar S, et al